Kelly Timothy Edwin 4
4 · Praxis Precision Medicines, Inc. · Filed Jul 31, 2024
Insider Transaction Report
Form 4
Kelly Timothy Edwin
Chief Financial Officer
Transactions
- Award
Common Stock
2024-07-29+7,800→ 12,140 total - Award
Stock Option (Right to Buy)
2024-07-29+36,400→ 36,400 totalExercise: $56.94Exp: 2034-07-29→ Common Stock (36,400 underlying)
Footnotes (2)
- [F1]Mr. Kelly was awarded 7,800 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on January 12, 2025, subject to the reporting person's continued service through each vesting date. The restricted stock units have no expiration date.
- [F2]The shares underlying this stock option vested as to 7/48ths on July 29, 2024 and the remaining shares vest in substantially equal monthly installments over the following 41 months, subject to the reporting person's continued service through each vesting date.